NRG Oncology is a prestigious organization committed to advancing cancer research through a collaborative network of professionals and committees. Specializing in clinical trials, NRG Oncology focuses on understanding and improving treatment outcomes across various cancer types, including brain tumors, breast cancer, gastrointestinal cancers, lung cancer, gynecologic cancers, and more. Their extensive research resources encompass patient study materials, biospecimen access, and robust data management resources, all aimed at facilitating innovative cancer care.

The organization emphasizes patient-centered outcomes and strives to enhance health care access and delivery through its dedicated committees. With an unwavering commitment to quality assurance and statistical reporting, NRG Oncology ensures that every trial maintains the highest standards of ethical responsibility and effectiveness. Their initiatives also support education and mentoring for emerging researchers, fostering a comprehensive approach to tackling the complexities of cancer treatment and research. By leveraging observations from clinical trials, NRG Oncology plays a pivotal role in shaping the future of oncology care and research.